Chromosomal instability shapes spatial and temporal phenotypic diversity in a malignant peripheral nerve sheath tumour
Haixi YaniD, Jonas DemeulemeesteriD, Annelien VerfaillieiD, Yixiao ChengiD, Yidan PaniD, Cristina CotobaliD, Sophia WardiD, Alexander SteiniD, Tom LesluyesiD, Tom L. KaufmanniD, Roland F. SchwarziD, Thierry VoetiD, Charles SwantoniD, Simone ZaccariaiD, Adrienne Margaret FlanaganiD, Maxime TarabichiiD, Peter Van LooiD
Abstract
Understanding the spatial and temporal dynamics of tumour evolution is crucial for determining the drivers of cancer progression. Linking genotype to phenotype across a tumour remains challenging, however. Here, we use single-cell and spatial multi-omics to comprehensively profile a primary malignant peripheral nerve sheath tumour (MPNST) and its multifocal recurrence. Combining the native barcoding system from extensive heterogeneity in copy number alterations with mutation data, we resolve the evolutionary tree of this tumour, revealing a branching structure suggestive of ongoing chromosomal instability. We show that gene dosage effects contribute to phenotypic diversity and scale predominantly linearly with copy number. Using spatial genomics assisted by laser capture microdissection and spatial transcriptomics, we performed in situ lineage tracing in this human tumour, elucidating the relationship between local expansions and interactions between tumour cells and the microenvironment. These findings demonstrate the potential of combined bulk, single-cell and spatial techniques to dissect cancer evolution in time and space and link genotype to phenotype in detail.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA
I. Cortes-Ciriano, C. D. Steele, … D. T. Miller·bioRxiv·May 3, 2022
- A detailed landscape of genomic alterations in malignant peripheral nerve sheath tumor cell lines challenges the current MPNST diagnosis
Miriam Magallón‐Lorenz, Ernest Terribas, … Eduard Serra·bioRxiv·May 7, 2022
- Identification of Malignant Peripheral Nerve Sheath Tumor subtypes with distinct genomic identities
Miriam Magallón‐Lorenz, Juana Fernández‐Rodríguez, … Bernat Gel·bioRxiv·Apr 2, 2026
- Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology
H. Bhatia^, A. T. Larsson^, … A. C. Hirbe·bioRxiv·Apr 29, 2022
- Multi-omics integration of malignant peripheral nerve sheath tumors identifies potential targets based on chromosome 8q status
Belinda B. Garana, Jiawan JC Wang, … Sara J.C. Gosline·bioRxiv·Jan 27, 2026
- Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target
Jacqueline D. Peacock, Matthew G. Pridgeon, … Matthew R. Steensma·bioRxiv·Oct 5, 2017